PHS
PFM Health Sciences Portfolio holdings
AUM
$950M
1-Year Est. Return
57.92%
This Fund
S&P 500
1 Year Est. Return
+57.92%
AUM
$950M
AUM Growth
-$37.5M
(-3.8%)
Holding
97
Top Buys
| 1 | +$22.3M | |
| 2 | +$15.9M | |
| 3 | +$12.9M | |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$12.8M |
| 5 |
Merit Medical Systems
MMSI
|
+$12.7M |
Top Sells
| 1 | +$23.2M | |
| 2 | +$20.5M | |
| 3 | +$19.8M | |
| 4 |
Centene
CNC
|
+$18.9M |
| 5 |
United Therapeutics
UTHR
|
+$13.9M |
Sector Composition
| 1 | Healthcare | 98.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Tenet Healthcare
THC
$14B
| $75.2M | 7.92% |
398,567
+800
|
|
||
2
Eli Lilly
LLY
$1.01T
| $60.5M | 6.37% |
65,762
-2,527
|
|
||
3
Penumbra
PEN
$12.6B
| $45.9M | 4.83% |
139,779
-5,392
|
|
||
4
Axsome Therapeutics
AXSM
$12B
| $44.7M | 4.7% |
264,304
+12,742
|
|
||
5
Ascendis Pharma A/S
ASND
$13B
| $34.8M | 3.66% |
152,034
-25,651
|
|
||
6
Jazz Pharmaceuticals
JAZZ
$15B
| $33.7M | 3.54% |
178,144
+127,633
|
|
||
7
Neurocrine Biosciences
NBIX
$16.5B
| $28.4M | 2.99% |
215,678
+52,481
|
|
||
|
8
United Therapeutics
UTHR
$23.3B
| $23.6M | 2.48% |
39,805
-27,938
|
|
||
9
Glaukos
GKOS
$7.34B
| $23.2M | 2.44% |
215,685
+14,009
|
|
||
|
CNTA
10
Centessa Pharmaceuticals
CNTA
$6.13B
| $21M | 2.21% |
528,224
-63,377
|
|
||
11
Inhibrx
INBX
$1.28B
| $20.5M | 2.16% |
305,431
+39,914
|
|
||
12
Edwards Lifesciences
EW
$49.5B
| $20.4M | 2.14% |
254,510
+7,675
|
|
||
13
BridgeBio Pharma
BBIO
$13.2B
| $19.1M | 2.01% |
257,747
-48,759
|
|
||
|
14
Madrigal Pharmaceuticals
MDGL
$11.2B
| $17.9M | 1.88% |
34,146
+26,888
|
|
||
15
Indivior Pharmaceuticals
INDV
$4.45B
| $17.5M | 1.84% |
574,666
+213,971
|
|
||
16
UnitedHealth
UNH
$363B
| $15.7M | 1.65% |
58,038
+7,499
|
|
||
17
Dianthus Therapeutics
DNTH
$4.4B
| $14.4M | 1.52% |
172,137
+72,561
|
|
||
18
Abbott
ABT
$159B
| $14.4M | 1.52% |
+140,432
|
|
||
19
Revolution Medicines
RVMD
$31.7B
| $13.7M | 1.44% |
140,770
-10,683
|
|
||
20
Acadia Healthcare
ACHC
$2.25B
| $13.6M | 1.43% |
+582,745
|
|
||
21
NeoGenomics
NEO
$1.42B
| $13.2M | 1.39% |
1,784,552
+90,501
|
|
||
22
Cooper Companies
COO
$13.1B
| $12.1M | 1.28% |
169,829
+69,027
|
|
||
23
Natera
NTRA
$30.8B
| $12M | 1.26% |
+60,004
|
|
||
24
Integer Holdings
ITGR
$3.12B
| $11.9M | 1.25% |
135,081
+28,496
|
|
||
25
Rhythm Pharmaceuticals
RYTM
$5.93B
| $11.9M | 1.25% |
136,621
+96,411
|
|